Cargando…

Associations of Circulating Osteoglycin With Bone Parameters and Metabolic Markers in Patients With Diabetes

OBJECTIVE: Circulating osteoglycin may facilitate the crosstalk between bone and pancreas to empower adaptation of bone mass to whole body energy balance. We aimed to examine whether osteoglycin is associated with bone and metabolic parameters and if osteoglycin levels differ between patients with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Starup-Linde, Jakob Kau, Viggers, Rikke, Langdahl, Bente, Gregersen, Soeren, Lykkeboe, Simon, Handberg, Aase, Vestergaard, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006932/ https://www.ncbi.nlm.nih.gov/pubmed/33790870 http://dx.doi.org/10.3389/fendo.2021.649718

Ejemplares similares

Bone Density and Structure in Overweight Men With and Without Diabetes
por: Starup-Linde, Jakob, et al.
Publicado: (2022)

Glucose Tolerance Tests and Osteocalcin Responses in Healthy People
por: Starup-Linde, Jakob, et al.
Publicado: (2018)

SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: A nationwide cohort study
por: Al-Mashhadi, Zheer Kejlberg, et al.
Publicado: (2022)

The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
por: Viggers, Rikke, et al.
Publicado: (2022)

Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study
por: Viggers, Rikke, et al.
Publicado: (2021)

The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study
por: Al-Mashhadi, Zheer Kejlberg, et al.
Publicado: (2022)

Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone
por: Starup-Linde, Jakob
Publicado: (2013)

The Effects of 12-Weeks Whey Protein Supplements on Markers of Bone Turnover in Adults With Abdominal Obesity – A Post Hoc Analysis
por: Fuglsang-Nielsen, Rasmus, et al.
Publicado: (2022)

Editorial: Diabetes and bone - from cell to human
por: Vestergaard, Peter, et al.
Publicado: (2022)

Diabetes and bone
por: Hygum, Katrine, et al.
Publicado: (2019)

Associations with fracture in patients with diabetes: a nested case–control study
por: Starup-Linde, Jakob, et al.
Publicado: (2016)

Predictors of Mortality Subsequent to a Fracture in Diabetes Mellitus Patients
por: Westberg-Rasmussen, Sidse, et al.
Publicado: (2015)

Type 1 Diabetes and Bone Fragility: Links and Risks
por: Starup-Linde, Jakob, et al.
Publicado: (2019)

Skeletal Fragility in Type 2 Diabetes Mellitus
por: Starup-Linde, Jakob, et al.
Publicado: (2018)

Osteoglycin, a novel coordinator of bone and glucose homeostasis
por: Lee, N.J., et al.
Publicado: (2018)

The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis
por: Kampmann, Andreas, et al.
Publicado: (2008)

Osteoglycin: An ECM Factor Regulating Fibrosis and Tumorigenesis
por: Nulali, Jiayida, et al.
Publicado: (2022)

Osteoglycin – A switch from angiogenesis to T-cell recruitment?
por: Dimberg, Anna
Publicado: (2018)

Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs
por: Chen, Xia, et al.
Publicado: (2017)

Low Levels of Plasma Osteoglycin in Patients with Complex Coronary Lesions
por: Seki, Toshiki, et al.
Publicado: (2018)

Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer
por: Hu, Xiang, et al.
Publicado: (2018)

C/EBPβ LIP augments cell death by inducing osteoglycin
por: Wassermann-Dozorets, Rina, et al.
Publicado: (2017)

Osteoglycin inhibition by microRNA miR-155 impairs myogenesis
por: Freire, Paula Paccielli, et al.
Publicado: (2017)

Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes—A Systematic Review
por: Viggers, Rikke, et al.
Publicado: (2023)

Vertebrate SLRP family evolution and the subfunctionalization of osteoglycin gene duplicates in teleost fish
por: Costa, R. A., et al.
Publicado: (2018)

The Effect of Effervescent and Buffered Alendronate Compared to Conventional Alendronate on Markers of Bone Turnover: A Randomized Non-inferiority Trial
por: Hikmet, Rawan, et al.
Publicado: (2023)

Serum levels of iCAF‐derived osteoglycin predict favorable outcome in pancreatic cancer
por: Dings, Mark P. G., et al.
Publicado: (2022)

Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling
por: Mei, Yu, et al.
Publicado: (2017)

Osteoglycin as a Potential Biomarker of Mild Kidney Function Impairment in Type 2 Diabetes Patients
por: González-Salvatierra, Sheila, et al.
Publicado: (2021)

Circulating microRNAs Are Associated With Metabolic Markers in Adolescents With Hepatosteatosis
por: Lin, Haixia, et al.
Publicado: (2022)

Circulating liver function markers and the risk of COPD in the UK Biobank
por: Du, Wencong, et al.
Publicado: (2023)

Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals
por: Knøsgaard, L, et al.
Publicado: (2014)

Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
por: Cantini, Giulia, et al.
Publicado: (2021)

Maternal adiposity, smoking, and thyroid function in early pregnancy
por: Andersen, Stine Linding, et al.
Publicado: (2021)

Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
por: Hu, Xiang, et al.
Publicado: (2018)

Is subcutaneous adipose tissue expansion in people living with lipedema healthier and reflected by circulating parameters?
por: Nankam, Pamela A. Nono, et al.
Publicado: (2022)

A flow cytometric method for characterization of circulating cell-derived microparticles in plasma
por: Nielsen, Morten Hjuler, et al.
Publicado: (2014)

Relationship between indices of circulating blood cells and bone homeostasis in osteoporosis
por: Li, Yuan, et al.
Publicado: (2022)

Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin
por: Botha, Jaco, et al.
Publicado: (2018)

Association of circulating miRNAS in patients with Alstrőm and Bardet-Biedl syndromes with clinical course parameters
por: Zmyslowska, Agnieszka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ren4lb8l4mbhaodl6m6kpcf8o